0      0

JL1118EH - JL1118EH: Time to Resolution of Myelosuppression and Associated Hospitalization in Patients With Newly-Diagnosed Acute Myeloid Leukemia (AML) Treated With Ivosidenib (IVO) + Azacitidine (AZA) Compared to Placebo (PBO) + AZA

‐ Oct 25, 2023 2:00pm

Full author listing

Authors: Giulia Rivoli MD,1

Germana Beltrami MD,1 Anna Maria Raiola MD,1 Alida Dominietto MD,1 Marcello Riggi MD,2 Emanuele Angelucci MD1

1Ematologia e terapie cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy; 2Stemline Therapeutics Switzerland GmbH, Zug, Switzerland


You must be logged in and own this session in order to post comments.